Garde Capital’s Microbot Medical MBOT Stock Holding History

Garde Capital’s Portfolio MBOT Stock Details MBOT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-2	Closed	-$6	–	572
2025 Q2	$6	Hold	2	–	–	﹤0.01%	837
2025 Q1	$4	Buy	+2	New	+$4	﹤0.01%	827

Other funds holding MBOT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

HCM

Heights Capital Management San Francisco, California $359M AUM 7.93% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

DnB Asset Management Oslo, Norway $28B AUM 26% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

EAM Investors Solana Beach, California $866M AUM 377.14% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Garde Capital's MBOT Position: Q3 2025 in Review

Garde Capital sold out of Microbot Medical (MBOT) in Q3 2025, closing a stake of 2 shares — an estimated $6 sold.

Garde Capital first reported a position in MBOT in Q1 2025 and held it in 2 quarters. The position peaked at $6 in Q2 2025. 67 funds tracked by Wall St. Rank hold MBOT as of Q3 2025.

Garde Capital reported no remaining Microbot Medical position as of Q3 2025 after selling out during the quarter.
Garde Capital sold 2 Microbot Medical shares in Q3 2025, an estimated $6.
Garde Capital first reported a position in Microbot Medical in Q1 2025 and held it in 2 quarters.
Garde Capital's Microbot Medical position peaked at $6 in Q2 2025.
67 funds tracked by Wall St. Rank held Microbot Medical as of Q3 2025.

Based on Garde Capital's 13F filing for Q3 2025, filed 16 Dec 2025.